Significant Glucose-Lowering Efficacy Of Sitagliptin, Investigational Drug For Type 2 Diabetes, When Taken With Metformin
Thu, 14 Sep 2006 08:00 AM EST
... New data presented for the first time today at the 42nd annual meeting of the European Association for the Study of Diabetes (EASD) in Copenhagen demonstrated in patients off therapy at randomization a significant mean placebo-subtracted reduction in HbA1c of 2. [click link for full article] ...
Related Topics
- Diabetes - Type 1
- Diabetes - Type 2
- Juvenile Diabetes
- Glucose
- Rosiglitazone and Metformin
- Diabetes
- Diabetes and Pregnancy
- Rosiglitazone
- Blood Glucose Monitoring
- Metformin
- Drug Side Effects
- Diabetes Insipidus
- Glyburide
- Gestational Diabetes
- Laboratory Tests
- Cholesterol
- Drug Safety
- Prescription Drugs
- Type 1 diabetes
- Type 2 diabetes

Not Signed In -


